| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash (used in) provided by investing activities | -1,256 | -6,910 |
| Proceeds from issuance of common stock under employee stock purchase plan | 24 | 24 |
| Net cash provided by financing activities | 24 | 24 |
| Net decrease in cash, cash equivalents and restricted cash | -27,564 | -28,550 |
| Cash and cash equivalents at beginning of period | 49,069 | - |
| Cash and cash equivalents at end of period | 21,505 | - |
Athira Pharma, Inc. (ATHA)
Athira Pharma, Inc. (ATHA)